Companies: 10,795·Total market cap: $144.5T
Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSENASDAQHealthcare● Active
$25.13
$-0.20(-0.79%)
Market Cap$1.7B
P/E Ratio
52W High$27.98
52W Low$12.56
Overview

Pulse Biosciences, Inc.(PLSE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PLSE · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.35M$0.00M$0.00M$0.70M$1.42M
Cost of Revenue$1.61M$0.00M$1.21M$11.94M$1.97M
Gross Profit($1.26M)$0.00M($1.21M)($11.24M)($0.55M)
Gross Margin %(computed)-360.00%-38.79%
Operating Expenses
R&D Expenses$44.72M$32.34M$27.80M$20.84M$28.64M
G&A Expenses$0.00M$23.92M$15.78M$13.96M$19.07M
Total Operating Expenses$75.68M$56.26M$42.37M$46.81M$62.46M
Operating Income($76.94M)($56.26M)($43.57M)($58.06M)($63.01M)
Operating Margin %(computed)
Interest Income$4.21M$2.67M$2.46M$0.00M$0.00M
Interest Expense$0.00M$0.00M$1.10M$0.00M$0.00M
Income Before Tax($72.78M)($53.59M)($42.21M)($58.51M)($63.66M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($72.78M)($53.59M)($42.21M)($58.51M)($63.66M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.08$-0.92$-0.88$-1.72$-2.28
Wtd Avg Shares67.40M58.40M48.04M33.94M27.96M
EBITDA($71.71M)($55.08M)($42.37M)($56.70M)($61.87M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Pulse Biosciences, Inc.

关于Pulse Biosciences, Inc.(PLSE)损益表

Pulse Biosciences, Inc.(PLSE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PLSE实现营收$0.00B,毛利润($0.00B)(毛利率-360.00%),净利润($0.07B)(净利率-20794.57%)。

常见问题

PLSE · 4 问

Pulse Biosciences, Inc.(PLSE)2025财年营收为$0.00B,同比up—%。

PLSE revenuePLSE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08